检索结果-南通市图书馆

The burden and long-term trends of breast cancer by different menopausal status in China

Journal of the National Cancer Center 2024年第4期4卷 326-334页

作者： shaoyuan lei Rongshou Zheng Siwei Zhang Wenqiang Wei Department of Evidence-Based Medicine Xuanwu HospitalCapital Medical UniversityBeijingChina Office for Cancer Registry National Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChina Beijing Municipal Geriatric Medical Research Center BeijingChina

Background: The burden of breast cancer in women of different menopausal status has not been assessed in China previously. We aim to evaluate and project the burden of breast cancer in different menopausal status in China. Methods: The incidence and mortality of breast cancer were estimated using the data of 554 cancer registries in 2017 and the trends of incidence and mortality of 112 cancer registries from 2010 to 2017. Data from 22 continued cancer registries from 2000 to 2017 were applied for long-term trend projection to 2030 using the Bayesian age- period-cohort model. Menopausal status was stratified by age, with premenopause defined as chronological age < 45 years, perimenopause defined as 45-54 years, and postmenopause defined as ≥ 55 years. Results: Approximately 352,300 incident cases and 74,200 deaths of breast cancer occurred in China in 2020, contributing to 2.6 million disability-adjusted life years (DALYs). Perimenopausal women had the highest inci- dence, prevalence, and DALYs rates, with the rates being 100.3 per 100,000, 819.2 per 100,000 and 723.1 per 100,000 persons. While postmenopausal women had the highest mortality rates (25.5 per 100,000 persons). From 2000 to 2017, the largest increase in incidence and mortality for breast cancer was observed in postmenopausal women with an average annual percentage change (AAPC) of 5.6% and 2.94%. The number of breast cancer cases and deaths will increase to 452,000 and 98,800 in 2030, resulting in 3.2 million DALYs. Conclusions: The burden of breast cancer is rapidly increasing in China and varies among different menopausal status. Specific prevention and control strategies for women in different menopausal status will be more helpful in reducing the rapidly growing trends of breast cancer.

关键词： Breast cancer Menopausal status Long-term trends China

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030

引用

Cancer Biology & Medicine 2021年第3期18卷 900-909页

作者： shaoyuan lei Rongshou Zheng Siwei Zhang Ru Chen Shaoming Wang Kexin Sun Hongmei Zeng Wenqiang Wei Jie He Office for Cancer Registry National Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Science and Peking Union Medical CollegeBeijing 100021China Department of Thoracic Surgery National Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Science and Peking Union Medical CollegeBeijing 100021China

Objective:Breast cancer was the most common cancer and the fifth cause of cancer deaths among women in China in *** evaluation of the long-term incidence and mortality trends and the prediction of the future burden of breast cancer could provide valuable information for developing prevention and control ***:The burden of breast cancer in China in 2015 was estimated by using qualified data from 368 cancer registries from the National Central Cancer *** cases and deaths in 22 cancer registries were used to assess the time trends from 2000 to 2015.A Bayesian age-period-cohort model was used to project the burden of breast cancer to ***:Approximately 303,600 new cases of breast cancer(205,100 from urban areas and 98,500 from rural areas)and 70,400 breast cancer deaths(45,100 from urban areas and 24,500 from rural areas)occurred in China in *** regions of China had the highest incidence and mortality *** most common histological subtype of breast cancer was invasive ductal carcinoma,followed by invasive lobular *** age-standardized incidence and mortality rates increased by 3.3%and 1.0%per year during 2000–2015,and were projected to increase by more than 11%until *** in risk and demographic factors between 2015 and 2030 in cases are predicted to increase by approximately 13.3%and 22.9%,whereas deaths are predicted to increase by 13.1%and 40.9%,***:The incidence and mortality of breast cancer continue to increase in *** are no signs that this trend will stop by 2030,particularly in rural *** breast cancer prevention strategies are therefore urgently needed in China.

关键词： Breast cancer temporal trends prediction cancer registry China

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Global patterns of breast cancer incidence and mortality:A population-based cancer registry data analysis from 2000 to 2020

引用

Cancer Communications 2021年第11期41卷 1183-1194页

作者： shaoyuan lei Rongshou Zheng Siwei Zhang Shaoming Wang Ru Chen Kexin Sun Hongmei Zeng Jiachen Zhou Wenqiang Wei Office for Cancer Registry National Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing 100021P.R.China Department of Epidemiology and Biostatistics School of Public HealthXi’an Jiaotong University Health Science CenterXi’anShaanxi 710061P.R.China

Background:Breast cancer is the most commonly diagnosed cancer and leading cause of cancer death among women worldwide but has patterns and trends which vary in different *** study aimed to evaluate the global patterns of breast cancer incidence and mortality and analyze its temporal trends for breast cancer prevention and ***:Breast cancer incidence and mortality data in 2020 were obtained from the GLOBOCAN online *** data from the Cancer Incidence in Five Continents Time Trends,the International Agency for Research on cancer mortality and China National Central Cancer Registry were used to analyze the time trends from 2000 to 2015 through Joinpoint regression,and annual average percent changes of breast cancer incidence and mortality were *** between Human Development Index and breast cancer incidence and mortality were estimated by linear ***:There were approximately 2.3 million new breast cancer cases and 685,000 breast cancer deaths worldwide in *** incidence and mortality varied among countries,with the age-standardized incidence ranging from the highest of 112.3 per 100,000 population in Belgium to the lowest of 35.8 per 100,000 population in Iran,and the age-standardized mortality from the highest of 41.0 per 100,000 population in Fiji to the lowest of 6.4 per 100,000 population in South *** peak age of breast cancer in some Asian and African countries were over 10 years earlier than in European or American *** for the trends of breast cancer,the age-standardized incidence rates significantly increased in China and South Korea but decreased in the United States of America(USA)during ***,the age-standardized mortality rates significantly increased in China and South Korea but decreased in the United Kingdom,the USA,and Australia during 2000 and ***:The global burden of breast cancer is rising fast and varies greatly among *** inci

关键词： Breast cancer mortality patterns incidence time trends cancer registry cancer trends

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Global burden and trends of lung cancer incidence and mortality

引用

Chinese Medical Journal 2023年第13期136卷 1583-1590页

作者： Chao Li shaoyuan lei Li Ding Yan Xu Xiaonan Wu Hui Wang Zijin Zhang Ting Gao Yongqiang Zhang Lin Li Department of Oncology Beijing HospitalNational Center of GerontologyInstitute of Geriatric MedicineChinese Academy of Medical SciencesBeijing 100730China Office for Cancer Registry National Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing 100021China Department of Disease and Infection Control National Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing 100021China

Background:Lung cancer has been the leading cause of cancer-related deaths worldwide for many *** study aimed to investigate the global patterns and trends of lung ***:Lung cancer incidence and mortality were derived from the GLOBOCAN 2020 *** data from Cancer Incidence in Five Continents Time Trends were used to analyze the temporal trends from 2000 to 2012 using Joinpoint regression,and average annual percent changes were *** association between the Human Development Index and lung cancer incidence and mortality was assessed by linear ***:An estimated 2.2 million new lung cancer cases and 1.8 million lung cancer-related deaths occurred in *** age-standardized incidence rate(ASIR)ranged from 36.8 per 100,000 in Demark to 5.9 per 100,000 in *** age-standardized mortality rate(ASMR)varied from 32.8 per 100,000 in Poland to 4.9 per 100,000 in *** ASIR and ASMR were approximately twice higher in men than in *** ASIR of lung cancer showed a downward trend in the United States of America(USA)between 2000 and 2012,and was more prominent in *** age-specific incidence rates of lung cancer for ages of 50 to 59 years showed an upward trend in China for both men and ***:The burden of lung cancer is still unsatisfactory,especially in developing countries like *** the effectiveness of tobacco control and screening in developed countries,such as the USA,there is a need to strengthen health education,accelerate the establishment of tobacco control policies and regulations,and improve early cancer screening awareness to reduce the future burden of lung cancer.

关键词： Lung neoplasms Incidence Mortality Early detection of cancer China United States

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

伤残权重在恶性肿瘤疾病负担研究中的进展

引用

中华肿瘤杂志 2021年第7期43卷 756-761页

作者：雷少元郑荣寿魏文强国家癌症中心国家肿瘤临床医学研究中心中国医学科学院北京协和医学院肿瘤医院肿瘤登记办公室100021

恶性肿瘤是威胁人类健康的主要公共卫生问题之一,疾病负担沉重。伤残调整寿命年(DALYs)是评价疾病负担应用最为广泛的指标之一,伤残权重是计算DALYs必不可少的参数,伤残权重值直接影响疾病负担测算的结果。文章就国内外恶性肿瘤伤残权... 详细信息

恶性肿瘤是威胁人类健康的主要公共卫生问题之一,疾病负担沉重。伤残调整寿命年(DALYs)是评价疾病负担应用最为广泛的指标之一,伤残权重是计算DALYs必不可少的参数,伤残权重值直接影响疾病负担测算的结果。文章就国内外恶性肿瘤伤残权重的评估方法、存在问题及研究进展进行梳理汇总,以期为中国人群中恶性肿瘤伤残权重的估计提供参考依据。

关键词：恶性肿瘤疾病负担伤残调整寿命年伤残权重

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Incidence, mortality, and disability-adjusted life years of female breast cancer in China, 2022

引用

中华医学杂志(英文版) 2024年第20期137卷 2429页

作者： Sun Kexin Zhang Bailin lei shaoyuan Zheng Rongshou Liang Xin Li Li Feng Xiaolong Zhang Siwei Zeng Hongmei Yao Yifei Ma Peiqing Wang Shaoming Chen Ru Han Bingfeng Wei Wenqiang He Jie Office of Cancer Registry National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China Department of Breast Surgical Oncology National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China Department of Evidence-Based Medicine Xuanwu Hospital Capital Medical University Beijing China Medical Statistics Office National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China Department of Pathology National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China Department of Thoracic Surgery National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

Background: Breast cancer is ranked among the most prevalent malignancies in the Chinese female population. However, comprehensive reports detailing the latest epidemiological data and attributable disease burden have not been extensively ***: In 2018, high-quality cancer surveillance data were recorded in 700 population-based cancer registries in China. We extracted data on female breast cancers (International Classification of Diseases, Tenth Revision [ICD-10]: C50) and estimated the incidence and mortality in 2022 according to the baseline data and corresponding trends from 2010 to 2018. Pathological types were classified according to the ICD for Oncology, 3rd Edition codes. Disability-adjusted life years (DALYs) were calculated as the sum of the years of life lost (YLLs) and years lived with disability (YLDs).Results: In 2022, approximately 357,200 new female breast cancer cases and 75,000 deaths occurred in China, accounting for 15.59% and 7.94% of total new cancer cases and deaths, respectively. The age-standardized incidence rate (ASIR) was 33.04 per 100,000. When analyzed by pathological type, the ASIRs for papillary neoplasms, invasive breast carcinoma, rare and salivary gland-type tumors, and other types were 1.13, 29.79, 0.24, and 1.88 per 100,000, respectively. The age-standardized mortality rate (ASMR) was 6.10 per 100,000. A total of 2,628,000 DALYs were found to be attributable to female breast cancer in China, comprising 2,278,300 YLLs and 349,700 YLDs. The ASIR, ASMR, and age-standardized rate (ASR) for DALYs in urban areas were consistently higher than those in rural areas. We observed a four-fold increase in the ASIR and ASR for DALYs and an eight-fold increase in the ASMR among females over 55 years compared with those aged under 55 ***: These data provide invaluable insights into the latest epidemiology of female breast cancer in China and highlight the urgency for disease prevention and control strategy formulation.

关键词： Female Breast cancer Incidence Mortality DALYs China Early detection of cancer Disease burden Invasive breast carcinoma Quality of life

来源：

同方期刊数据库评论

在线全文

同方期刊数据库

学校读者我要写书评

暂无评论

中国2015年分省份乳腺癌死亡发病比分析

引用

肿瘤预防与治疗 2021年第7期34卷 591-596页

作者：雷少元郑荣寿张思维魏文强国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院肿瘤登记办公室北京100021

目的:计算我国各省份乳腺癌的死亡发病比,并分析与人均国内生产总值、卫生资源密度等级的关系,为优化我国各省份医疗卫生资源配置提供数据支持和建议。方法:利用符合质量控制标准的387个肿瘤登记处乳腺癌发病和死亡的数据,汇总估计各省... 详细信息

目的:计算我国各省份乳腺癌的死亡发病比,并分析与人均国内生产总值、卫生资源密度等级的关系,为优化我国各省份医疗卫生资源配置提供数据支持和建议。方法:利用符合质量控制标准的387个肿瘤登记处乳腺癌发病和死亡的数据,汇总估计各省份死亡发病比。根据国家统计局和已发表的文献获得人均国内生产总值和卫生资源密度等级数据。采用线性回归分析死亡发病比与人均国内生产总值和卫生资源密度等级的关系。结果:2015年我国乳腺癌的死亡发病比为0.22。在30个省份中,新疆最高(0.40),浙江最低(0.13)。人均国内生产总值天津排名最高,甘肃排名最低,卫生资源密度等级上海排名第一,青海排名最低。人均国内生产总值、卫生资源密度等级与死亡发病比呈现显著相关。结论:我国各省份之间乳腺癌的死亡发病比差异较大,且与人均国内生产总值和卫生资源密度等级显著相关。未来政府应平衡各地区医疗资源配置,打破地域间的卫生资源局限性,为我国乳腺癌的预防和控制提供最优策略。

关键词：乳腺癌死亡发病比人均国内生产总值卫生资源密度

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

中国脑瘤发病和死亡流行现况及预测

引用

基础医学与临床 2024年第4期44卷 454-458页

作者：雷少元李玉龙孙菲刘宏军吴月郭艳苏首都医科大学宣武医院循证医学中心北京100053 中共中央办公厅警卫局保健处北京100034 首都医科大学宣武医院老年保健及疾病防治中心办公室北京100053 北京市老年病医疗研究中心北京100053

目的描述2020年中国脑瘤发病和死亡的流行现况,预测到2040年中国脑瘤发病和死亡负担,为更科学的制定我国脑瘤防治策略提供数据支持。方法提取国际癌症研究署(IARC)2020年Cancer Today数据库。采用Segi’s世界标准人口的年龄构成计算... 详细信息

目的描述2020年中国脑瘤发病和死亡的流行现况,预测到2040年中国脑瘤发病和死亡负担,为更科学的制定我国脑瘤防治策略提供数据支持。方法提取国际癌症研究署(IARC)2020年Cancer Today数据库。采用Segi’s世界标准人口的年龄构成计算脑瘤的年龄标化发病率和死亡率。分性别、年龄别描述中国脑瘤发病和死亡情况。利用《世界人口展望(2022)》数据结合脑瘤发病和死亡率预测到2040年中国脑瘤发病和死亡负担。结果 2020年中国脑瘤新发病例约8.0万人,死亡约6.5万人,年龄标化发病率和死亡率分别为4.1/10万和3.2/10万。中国脑瘤的年龄标化发病率低于美国、绝大部分欧洲、北美洲等地区脑瘤发病率,但高于非洲、中美洲、加勒比海等地区。2040年中国脑瘤的发病和死亡人数相比2020年分别增长32.1%和41.5%。结论中国脑瘤负担整体比较严重,需进一步明确人群脑瘤危险因素,有针对性地完善相应防控策略以降低脑瘤负担。

关键词：脑瘤发病率死亡率中国

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Highly active artificial potassium channels having record-high K^(+)/Na^(+) selectivity of 20.1

引用

Chinese Chemical Letters 2023年第12期34卷 189-195页

作者： Haowen Ma Ruijuan Ye lei Jin shaoyuan Zhou Changliang Ren Haisheng Ren Jie Shen Huaqiang Zeng College of Chemistry Fuzhou UniversityFuzhou 350116China School of Chemistry and Chemical Engineering Northwestern Polytechnical UniversityXi'an 710072China School of Pharmaceutical Sciences Xiamen UniversityXiamen 361102China Shenzhen Research Institute Xiamen UniversityShenzhen 518000China College of Chemical Engineering Sichuan UniversityChengdu 610065China

Replicating extraordinarily high membrane transport selectivity of protein channels in artificial channel is a challenging *** this work,we demonstrate that a strategic application of steric code-based social self-sorting offers a novel means to enhance ion transport selectivities of artificial ion channels,alongside with boosted ion transport *** specifically,two types of mutually compatible sterically bulky groups(benzo-crown ether and tert-butyl group)were appended onto a monopeptide-based scaffold,which can order the bulky groups onto the same side of a one-dimensionally aligned H-bonded *** steric repulsions among the same type of bulky groups(either benzo-crown ethers or tert-butyl groups),which are forced into proximity by H-bonds,favor the formation of hetero-oligomeric ensem-bles that carry an alternative arrangement of sterically compatible benzo-crown ethers and tert-butyl groups,rather than homo-oligomeric ensembles containing a single type of either benzo-crown ethers or tert-butyl *** with side chain tuning,this social self-sorting strategy delivers highly ac-tive hetero-oligomeric K+-selective ion channel(5F12-BF12)_(n),displaying the highest K+/Na+selectivity of 20.1 among artificial potassium channels and an excellent ECso value of 0.50μmol/L(0.62 mo1%relative to lipids)in terms of single channel concentration.

关键词： Supramolecular chemistry Artificial membrane transporters Artificial potassium channels Crown ethers Social self-sorting Transport selectivity

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

中国人群伤残权重测量:聚焦癌症,量化评估伤残权重对癌症疾病负担估计的影响

引用

Science Bulletin 2023年第13期68卷 1430-1438,M0004页

作者：雷少元郑荣寿张绍凯黄云超乔良宋冰冰贺宇彤杜灵彬王宁席云峰刘玉琴周金意张敏郑莹张永珍鞠雯魏文强 Office for Cancer Registry National Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing 100021China Department of Evidence-Based Medicine Xuanwu HospitalCapital Medical UniversityBeijing 100053China Department of Cancer Epidemiology and Prevention Affiliated Cancer Hospital of Zhengzhou UniversityHenan Cancer HospitalZhengzhou 450008China Yunnan Cancer Center/Yunnan Cancer Hospital Kunming 650118China Department of Cancer Prevention and Control Sichuan Cancer Hospital&InstituteSichuan Cancer CenterSchool of MedicineUniversity of Electronic Science and Technology of ChinaChengdu 610042China Institute of Cancer Prevention and Treatment Harbin Medical University/Institute of Cancer Prevention and TreatmentHeilongjiang Academy of Medical SciencesHeilongjiang Cancer CentreHarbin 150081China Department of Cancer Prevention and Control Hebei Medical University Fourth HospitalShijiazhuang 050000China Department of Cancer Prevention Cancer Hospital of the University of Chinese Academy of Sciences/Zhejiang Cancer HospitalHangzhou 310005China Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing) Beijing Office for Cancer Prevention and ControlPeking University Cancer Hospital&InstituteBeijing 100142China The Inner Mongolia Autonomous Region Comprehensive Center for Disease Control and Prevention Hohhot 750306China Cancer Epidemiology Research Center Gansu Cancer HospitalLanzhou 730050China Department of Non-communicable Chronic Disease Control Jiangsu Provincial Center for Disease Control and PreventionNanjing 210009China Office of Cancer Prevention and Treatment Hubei Cancer HospitalTongji Medical CollegeHuazhong University of Science and TechnologyWuhan 430079China Department of Cancer Prevention Fudan University Shanghai Cancer CenterDepartment of OncologyShanghai Medical CollegeFudan UniversityShanghai 200032China Department of Epidemiology Shanxi

伤残权重对于量化评估非死亡相关健康损失至关重要.全球范围看,目前仅有少数国家或地区对伤残权重进行了评估,且极少有肿瘤特异性的伤残权重结果报道.本研究基于大样本人群估计中国人群肿瘤特异性伤残权重,并比较不同伤残权重对量化评... 详细信息

伤残权重对于量化评估非死亡相关健康损失至关重要.全球范围看,目前仅有少数国家或地区对伤残权重进行了评估,且极少有肿瘤特异性的伤残权重结果报道.本研究基于大样本人群估计中国人群肿瘤特异性伤残权重,并比较不同伤残权重对量化评估肿瘤疾病负担的影响.基于开放式网络调查,采用配对比较的方法进行伤残权重的测量.伤残寿命损失年(YLDs)估计为不同瘤种各时期肿瘤的患病人数与其对应时期的伤残权重乘积之和.研究共收集到44,069份有效调查问卷,估计了包含18类恶性肿瘤在内的254个健康状态的残疾权重.其中,诊断和初始治疗阶段的肿瘤特异性伤残权差异较大,脑瘤的伤残权重最高为0.619(95%不确定性区间(UI):0.606~0.632),口咽癌伤残权重最低,为0.167(95%UI:0.158~0.176).不同肿瘤伤残权重对YLDs估计影响较大,所有肿瘤合计的YLDs差异超过30%.本研究提供的肿瘤特异性伤残权重可以为精确估计肿瘤疾病负担提供重要的数据支持.

关键词： Years livedwithdisability Disabilityweights Cancer Disease burden

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：